PTC Therapeutics, Inc. (PTCT)
NASDAQ
Closed
Oct 23, 2026
Day's Range
59.9752 wk Range
58.80Overview - PTCT - PTC Therapeutics, Inc.
Key Statistics
Valuation
Enterprise Value
5.84B
P/E (Trailing)
7.50
P/E (Forward)
25.56
PEG Ratio
-0.03
Price / Sales (TTM)
5.01
Price / Book
-30.39
EV / EBITDA
34.14
Profitability
Gross Margin
94.47%
Profit Margin
-3.80%
Operating Margin
41.32%
Return on Assets
2.46%
Return on Equity
-332.48%
Ownership
Shares Outstanding
83.32M
Float
73.69M
Short % of Shares Outstanding
14.89%
Held by Insiders
7.31%
Held by Institutions
122.79%
Price stats
Beta
0.48
50-Day Avg
66.38
200-Day Avg
71.04
Dividends
Payout Ratio
0.00%
Analyst Consensus
14 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PTCT - PTC Therapeutics, Inc.
Peers - PTCT - PTC Therapeutics, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- PTCTNASDAQPTC Therapeutics, Inc.5.05BMarket Cap-10.71%52-week change7.50P/E (Trailing)-3.80%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - PTCT - PTC Therapeutics, Inc.
About
PTC Therapeutics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for people living with rare disorders. Its current portfolio includes treatments for conditions such as Duchenne muscular dystrophy, phenylketonuria, and aromatic L-amino acid decarboxylase…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
